Filing Overview
Hyliion Holdings Corp. filed this Form 8-K on October 23, 2020, reporting matters under Item 5.02 regarding the employment agreement of its Chief Financial Officer, Greg Van de Vere. The report does not contain quarterly or annual operating results.
Executive Compensation and Equity Awards
- Van de Vere entered into an initial one-year employment agreement effective October 23, 2020, with automatic successive 12-month renewals unless either party provides at least 90 days’ notice of non-renewal.
- Annual base salary is $400,000. He is also eligible for discretionary cash bonuses approved by the Board.
- Subject to Compensation Committee approval, he will receive a one-time time-based RSU award covering 100,000 common shares, vesting over four years.
- He will also receive a performance-based RSU award covering 500,000 common shares, vesting based on criteria established by the Compensation Committee over the period ending December 31, 2025.
- On October 16, 2020, all of Van de Vere’s unvested Company options granted before October 1, 2020 reportedly accelerated in vesting and exercisability under his prior employment agreement.
Termination and Change-in-Control Provisions
- If employment ends because of non-renewal, termination without cause, or resignation for good reason, subject to specified conditions, Van de Vere may receive 12 months of base salary, limited accelerated vesting of equity awards, up to 36 months to exercise vested options, and up to 12 months of COBRA reimbursement.
- Upon death or disability, specified unvested equity awards other than performance-based awards will fully vest and, if applicable, become exercisable.
- Upon a qualifying change in control, the performance-based RSUs may vest based on actual achievement of applicable criteria. The time-based RSUs will fully vest before closing if not assumed, substituted, or continued by the successor.
Financial Metrics and Material Period Comparisons
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics. It also does not provide a comparison with a prior period or describe material changes in financial performance.
Risks, Contingencies, and Unusual Items
- The equity awards are subject to continued service, Compensation Committee approval where applicable, and performance criteria for the performance-based RSUs.
- Potential future compensation expense and shareholder dilution may result from the 600,000 shares covered by the disclosed RSU awards, although the filing does not state the accounting value or expense impact.
- Severance and accelerated-vesting obligations could arise upon specified termination events or a change in control.
Investor Verification Items
- Review Exhibit 10.1 for the complete definitions of cause, good reason, disability, change in control, performance criteria, and severance conditions.
- Verify Compensation Committee approval and the final terms and grant-date valuation of the RSU awards.
- Assess the potential dilution and future stock-based compensation expense from the 100,000 time-based and 500,000 performance-based RSUs.
- Confirm the scope and value of the options that accelerated on October 16, 2020.